Related references
Note: Only part of the references are listed.Fragment-based design, docking, synthesis, biological evaluation and structure-activity relationships of 2-benzo/benzisothiazolimino-5-aryliden-4-thiazolidinones as cycloxygenase/lipoxygenase inhibitors
Phaedra Eleftheriou et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Molecular Docking and Pharmacophore Filtering in the Discovery of Dual-Inhibitors for Human Leukotriene A4 Hydrolase and Leukotriene C4 Synthase
Sundarapandian Thangapandian et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
From in silico target prediction to multi-target drug design: Current databases, methods and applications
Alexios Koutsoukas et al.
JOURNAL OF PROTEOMICS (2011)
Polyamines in Drug Discovery: From the Universal Template Approach to the Multitarget-Directed Ligand Design Strategy
Carlo Melchiorre et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
A comprehensive structure-activity analysis of protein kinase B-alpha (Akt1) inhibitors
Subhash Ajmani et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2010)
Synergistic therapeutic actions of herbal ingredients and their mechanisms from molecular interaction and network perspectives
X. H. Ma et al.
DRUG DISCOVERY TODAY (2009)
Mechanisms of drug combinations: interaction and network perspectives
Jia Jia et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Group-Based QSAR (G-QSAR): Mitigating Interpretation Challenges in QSAR
Subhash Ajmani et al.
QSAR & COMBINATORIAL SCIENCE (2009)
Discovery of Multitarget Inhibitors by Combining Molecular Docking with Common Pharmacophore Matching
Dengguo Wei et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Recent Advances in the Development of Multi-Kinase Inhibitors
Martin Krug et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2008)
How to design multi-target drugs: target search options in cellular networks
Tamas Korcsmaros et al.
EXPERT OPINION ON DRUG DISCOVERY (2007)
Fragments, network biology and designing multiple ligands
Richard Morphy et al.
DRUG DISCOVERY TODAY (2007)
Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3
Natalia V. Sergina et al.
NATURE (2007)
The role of VEGF and EGFR inhibition: Implications for combining anti-VEGF and anti-EGFR agents
Josep Tabernero
MOLECULAR CANCER RESEARCH (2007)
Multi-target therapeutics: when the whole is greater than the sum of the parts
Grant R. Zimmermann et al.
DRUG DISCOVERY TODAY (2007)
Innovation - A robustness-based approach to systems-oriented drug design
Hiroaki Kitano
NATURE REVIEWS DRUG DISCOVERY (2007)
The physicochemical challenges of designing multiple ligands
Richard Morphy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Advances toward new antidepressants beyond SSRIs:: 1-Aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities.: Part 5
K Takeuchi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer
Rita Nahta et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
MJ Millan
PHARMACOLOGY & THERAPEUTICS (2006)
Can we rationally design promiscuous drugs?
AL Hopkins et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2006)
Designed multiple ligands. An emerging drug discovery paradigm
R Morphy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action
B Ganter et al.
JOURNAL OF BIOTECHNOLOGY (2005)
Target-based drug discovery: is something wrong?
F Sams-Dodd
DRUG DISCOVERY TODAY (2005)
Application of predictive QSAR models to database mining:: Identification and experimental validation of novel anticonvulsant compounds
M Shen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
From magic bullets to designed multiple ligands
R Morphy et al.
DRUG DISCOVERY TODAY (2004)
Drug evolution concept in drug design: 1. Hybridization method
C Lazar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Development of human protein reference database as an initial platform for approaching systems biology in humans
S Peri et al.
GENOME RESEARCH (2003)
Innovation - Target discovery
MA Lindsay
NATURE REVIEWS DRUG DISCOVERY (2003)
Development and validation of k-nearest-neighbor QSPR models of metabolic stability of drug candidates
M Shen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
The importance of being earnest: Validation is the absolute essential for successful application and interpretation of QSPR models
A Tropsha et al.
QSAR & COMBINATORIAL SCIENCE (2003)
Issues and progress with protein kinase inhibitors for cancer treatment
J Dancey et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
QSAR Modeling using chirality descriptors derived from molecular topology
A Golbraikh et al.
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2003)
An alignment-independent versatile structure descriptor for QSAR and QSPR based on the distribution of molecular features
K Baumann
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2002)
Studies towards the next generation of antidepressants. Part 1: Indolylcyclohexylamines as potent serotonin reuptake inhibitors
KL Meagher et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
5-HT reuptake inhibitors with 5-HT1B/1D antagonistic activity:: A new approach toward efficient antidepressants
L Matzen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Novel variable selection quantitative structure-property relationship approach based on the k-nearest-neighbor principle
WF Zheng et al.
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2000)
Share Paper
